Facts & Figures
Year of foundation | 1870 |
| Global headquarters | Goettingen, Germany |
| Legal structure of the Group | Sartorius AG is listed on the stock exchange in Frankfurt, Germany. Sartorius manages its business in two legally independent subgroups, Sartorius Stedim Biotech S.A. and Sartorius Lab Holding GmbH. |
Operating structure of the Group | Sartorius conducts its operational business in two divisions: Bioprocess Solutions and Lab Products & Services. |
Global footprint | About 60 sites in more than 30 countries, thereof 22 production facilities. Including all sales subsidiaries and commercial agencies presence in more than 110 countries. |
| Annual sales revenue in 2017 | 1,406.6 million euros |
| - of which EMEA | 43% |
| - of which Americas | 32% |
| - of which in Asia | Pacific | 25% |
| - by Division Lab Products & Services | 28% |
| - by Division Bioprocess Solutions | 72% |
Underlying EBITDA Underlying EBITDA margin | 353.2 million euros 25.1% |
Capex ratio | 14.9% |
Number of employees (as Dec 31, 2017) | 7,500 |